Amanda K. Downey
Mississauga, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
One-year Real-world Outcomes With Faricimab in Neovascular Age-related Macular Degeneration.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: March 27, 2026
One-year Real-world Outcomes and Durability With Faricimab in Patients With Diabetic Macular Edema.
Journal: Ophthalmic surgery, lasers & imaging retina
Published: November 04, 2025
Universal Pharmacare and Contraceptive Dispensations Among Youth.
Journal: JAMA pediatrics
Published: August 18, 2025
Effect of universal no-cost coverage on use of long-acting reversible contraception and all prescription contraception: population based, controlled, interrupted time series analysis.
Journal: BMJ (Clinical research ed.)
Published: July 28, 2025
Does the Efficacy, Durability, and Safety of Faricimab for Diabetic Macular Edema in Randomized Trials Translate into Real-World Settings?
Journal: Ophthalmology and therapy
Published: July 10, 2025
Real-world treatment patterns and visual outcomes of faricimab in patients with diabetic macular oedema in the UK at 12 months: the FARWIDE-DMO study.
Journal: Eye (London, England)
Published: May 13, 2025
Real-world treatment patterns and visual outcomes of faricimab in patients with neovascular age-related macular degeneration in the UK at 12 months: the FARWIDE-nAMD study.
Journal: Eye (London, England)
Published: April 07, 2025
Real-World Evidence for Faricimab in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Scoping Review.
Journal: Ophthalmology science
Published: August 26, 2024
Showing 1-8 of 8
Last Updated: 09/26/2026